VANCOUVER, June 28 /CNW/ - Biotech Holdings (the "Company", TSXV: BIO;
OTC BB: BIOHF) reports that it is expanding distribution of its Sucanon
diabetes drug in Mexico and other markets.
The Company took over Sucanon distribution from an appointed marketing
company in September, 2006 and currently distributes through more than ten
chains. Retail chains distributing Sucanon include big-box retailer Wal-Mart
and drugstore chains Farmacias Benavides and Farmacias del Ahorro. Catalog and
call-center sales to better-off customers are conducted principally through
Internacional de Productos. Overall, the distribution system that has been
created allows Sucanon to be offered to Type II diabetics through
approximately 2,000 retail outlets.
The Company is also working to improve the availability of Sucanon to
poorer sectors of the Mexican population, who cannot afford to buy regularly
at normal retail prices. Earlier this month, the Company participated by
invitation at a "Diabetes and Society National Meeting" organized by the
Mexican Social Security Institute (Instituto Mexicano del Seguro Social or
IMSS) to find channels and methods by which government support for purchasing
of Sucanon can be extended among the less well-off. The IMSS is a government
institution which is involved in providing medical care for approximately
48 million people.
The Mexican Diabetes Federation recently expressed support for Sucanon in
an overview of insulin senstizers (see (see Endorsements at
Biotech recently signed a distribution agreement covering four markets in
Latin America see http://www.biotechltd.com/investor/read_news.asp?newsid=904
and is continuing to pursue distribution discussions in a number of Latin
American markets including Brazil and Argentina as well as in some markets
outside Latin America.
The Company also sells Sucanon, primarily to diabetics outside Mexico,
through its website, see www.sucanonhealth.com.
This release has been approved by the Board of Directors of Biotech
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
If you wish to be removed from Biotech Holdings' email news distribution
list, please reply by email, putting "remove" in the subject line.
Robert B. Rieveley, Pres.
On behalf of the Board of Directors
Any statements made in this release that are not based on historical fact
are forward-looking statements. Any forward-looking statements made in this
release represent management's best judgement as to what may occur in the
future. However, actual outcome and results are not guaranteed and are subject
to certain risks, uncertainties and assumptions and may differ materially from
what is expressed.
For further information:
For further information: Austin Rand at Biotech Holdings, 1-888-216-1111
(toll-free) 8 a.m. to 4 p.m. Pacific time; For background information on
Biotech Holdings, or to receive news updates, see www.biotechltd.com; The
Company can be reached by calling (604) 295-1119